the magic of mushrooms

[GeneChing]

Product Images

Sample Product Image from the Investigation of Illnesses Related to Diamond Shruumz-Brand Microdosing Chocolate Bars, Cones, & Gummies (June 2024)
Sample Product Image from the Investigation of Illnesses Related to Diamond Shruumz-Brand Microdosing Chocolate Bars (June 2024)
Sample Product Image from the Investigation of Illnesses Related to Diamond Shruumz-Brand Microdosing Chocolate Bars (June 2024)
Previous Update

August 14, 2024

As previously reported, FDA and state and local partners have collected multiple samples of Diamond Shruumz-brand products for testing and analysis. Sample analysis is ongoing; however, as of August 8, 2024, test results are available for 19 Diamond Shruumz-brand Chocolate Bars and have been summarized in the Sample Results section below. Samples of the Diamond Shruumz-brand Cones and Gummies have also been collected and testing and analysis is ongoing.

As of August 9, 2024, a total of 130 illnesses have been reported from 29 states; 53 have been hospitalized, and there are two potentially associated deaths.

August 8, 2024

As previously reported, FDA and state and local partners have collected multiple samples of Diamond Shruumz-brand products for testing and analysis. Sample analysis is ongoing; however, as of August 8, 2024, test results are available for 19 Diamond Shruumz-brand Chocolate Bars and have been summarized in the Sample Results section below. Samples of the Diamond Shruumz-brand Cones and Gummies have also been collected and testing and analysis is ongoing.

On August 2, 2024, FDA published an updated list of store names and locations known to sell Diamond Shruumz-brand products. All Diamond Shruumz-brand products have been recalled and should not be available for sale. If you identify a retailer (online or in-person) continuing to sell recalled Diamond Shruumz-brand product, please report this information to FDA.

As of August 2, 2024, a total of 113 illnesses have been reported from 28 states; 42 have been hospitalized, and there are two potentially associated deaths.

August 6, 2024

On August 2, 2024, FDA published an updated list of store names and locations known to sell Diamond Shruumz-brand products. All Diamond Shruumz-brand products have been recalled and should not be available for sale. If you know of a retailer (online or in-person) continuing to sell recalled Diamond Shruumz-brand product, you can report this information to FDA.

As of August 2, 2024, a total of 113 illnesses have been reported from 28 states; 42 have been hospitalized, and there are two potentially associated deaths.

July 30, 2024

On July 30,2024, FDA published a list of store names and locations known to sell Diamond Shruumz-brand products. This comes after FDA received numerous reports of retailers continuing to sell the recalled products.

All Diamond Shruumz-brand products have been recalled and should not be sold. Consumers should not purchase any Diamond Shruumz-brand products. If you know of a retailer (online or in-person) continuing to sell recalled Diamond Shruumz-brand product, you can report this information to FDA.

A list of store names and locations is available and will be updated as additional stores are identified.

As of July 29, 2024, a total of 78 illnesses have been reported from 28 states. Sixty-five (65) of the 78 people have reported seeking medical care, 40 have been hospitalized, and there are two potentially associated deaths under investigation.

July 23, 2024

As of July 22, 2024, a total of 74 illnesses have been reported from 28 states. Sixty-two (62) of the 74 people have reported seeking medical care, 38 have been hospitalized, and there are two potentially associated deaths under investigation.

July 16, 2024

As of July 15, 2024, a total of 69 illnesses have been reported from 28 states. Sixty (60) of the 69 people have reported seeking medical care, 36 have been hospitalized, and there is one potentially associated death under investigation.

FDA is aware that recalled Diamond Shruumz-brand products are still on the shelves at several smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC). FDA is monitoring the firm’s recall to assess its effectiveness.

FDA is working with the National Association of Convenience Stores and the National Smoke Shop Association to increase awareness of the recall. All Diamond Shruumz-brand products have been recalled and should not be available for sale. Consumers should not purchase or consume any Diamond Shruumz-brand products. If you have seen a store continuing to sell recalled Diamond Shruumz-brand products, you can report this information to FDA.

This advisory will be updated as additional information becomes available.

July 9, 2024

As of July 8, 2024, a total of 58 illnesses have been reported from 27 states. 50 of the 58 people have reported seeking medical care, 30 have been hospitalized, and there is one potentially associated death under investigation.

This advisory will be updated as additional information becomes available.

July 2, 2024

As of July 1, 2024, a total of 48 illnesses have been reported from 24 states including AL (1), AZ (6), CA (1), CO (1), FL (1), GA (3), IN (5), IA (3), KY (3), MD (1), MN (1), MO (1), MT (1), NV (1), NJ (2), NY (1), NC (3), ND (1), OH (2), OK (1), PA (2), SC (4), SD (1), and TN (2). Forty-six (46) of the 48 people have reported seeking medical care; Twenty-seven (27) have been hospitalized. There is one (1) potentially associated death under investigation.

This advisory will be updated as additional information becomes available.

continued next post

[GeneChing]

June 28, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies.

On June 27, 2024, Prophet Premium Blends, LLC of Santa Ana, CA, initiated a recall of all flavors of Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. According to the firm, these products contain muscimol, a chemical found in some mushrooms, that could be a potential cause of symptoms consistent with some symptoms observed in individuals who became ill after consuming Diamond Shruumz-brand products. FDA is evaluating this information.

As previously reported, FDA and state partners have collected multiple samples of Diamond Shruumz-brand products for testing and analysis. Additional sample analysis is ongoing, but as of June 25, 2024 test results for two individual chocolate bars collected from a retail store have identified the presence of the following:

Diamond Shruumz Dark Chocolate Bar
4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin)
desmethoxyyangonin
dihydrokavain
kavain
Diamond Shruumz Birthday Cake Chocolate Bar
4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin)
There may be variability in test results across products with different formulations as well as potential variability across lots and batches of the same product. Additional testing for the above Diamond Shruumz-brand Chocolate Bars, along with testing for other Diamond Shruumz-brand products, is in progress. FDA and CDC medical officers are interpreting these test results to understand the health risks of ingesting these chemical substances and to determine the appropriate next steps.

This advisory will be updated as additional information becomes available.

June 25, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies.

FDA has been in contact with the firm about a possible voluntary recall, but to date, the firm has not initiated the recall.

As part of this investigation, FDA and state partners have collected multiple samples of Diamond Shruumz-brand products for testing and analysis. Additional sample analysis is ongoing, but as of June 25, 2024 test results for two individual chocolate bars collected from a retail store have identified the presence of the following:

Diamond Shruumz Dark Chocolate Bar
4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin)
desmethoxyyangonin
dihydrokavain
kavain
Diamond Shruumz Birthday Cake Chocolate Bar
4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin)
There may be variability in test results across products with different formulations as well as potential variability across lots and batches of the same product. Additional testing for the above Diamond Shruumz-brand Chocolate Bars, along with testing for other Diamond Shruumz-brand products, is in progress. FDA and CDC medical officers are interpreting these test results to understand the health risks of ingesting these chemical substances and to determine the appropriate next steps.

This advisory will be updated as additional information becomes available.

June 18, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies.

As part of this investigation, FDA and state partners have collected multiple samples of Diamond Shruumz-brand Chocolate Bars and the analysis is ongoing. FDA's investigation is ongoing to determine the cause of these illnesses and the appropriate next steps.

As of June 17, 2024, a total of 26 illnesses have been reported from 16 states including AL (1), AZ (6), CA (1), IN (3), KY (2), MD (1), MN (1), MO (1), MT (1), NV (1), NJ (1), NY (1), NC (1), PA (1), SC (3), and TN (1). Twenty-five (25) of the 26 people have reported seeking medical care; 16 have been hospitalized. No deaths have been reported.

FDA has been in contact with the firm about a possible voluntary recall, but these discussions are still ongoing. This advisory will be updated as additional information becomes available.

June 11, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies.

As of June 10, 2024, additional Diamond Shruumz-brand products have been reported by people who became ill, including the Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. A total of 12 illnesses have been reported from eight states including AL (1), AZ (4), IN (2), KY (1), MO (1), NV (1), PA (1), and SC (1). All 12 people have reported seeking medical care; 10 have been hospitalized. No deaths have been reported. FDA is working to determine the cause of these illnesses and is considering the appropriate next steps. More information will be provided as it becomes available.

June 7, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Microdosing Chocolate Bars.

As of June 7, 2024, a total of eight illnesses have been reported from four states including AZ (4), IN (2), NV (1), and PA (1). All eight people have reported seeking medical care; six have been hospitalized. No deaths have been reported. FDA is working to determine the cause of these illnesses and is considering the appropriate next steps. More information will be provided as it becomes available.

Who to Contact
Consumers who have symptoms should contact their health care provider to report their symptoms and/or the Poison Help line to receive care.

To report a complaint or adverse event (illness or serious allergic reaction), you can

Call the poison centerExternal Link Disclaimer at 1-800-222-1222
Call an FDA Consumer Complaint Coordinator if you wish to speak directly to a person about your problem.
Complete an electronic Voluntary MedWatch form online.
Complete a paper Voluntary MedWatch form that can be mailed to FDA.

Is there any regulation overseeing shroom products now? Asking for a friend...

[mickey]

Greetings,

I have been observing the push for mushroom use for a few years. While I am not aware of a regulating body, the best advice given to those who are interested in pursuing mushroom use is to grow your own. I think it is the safest and the most responsible approach. I really don't give 2 fuks about those who are trying to cash in on its use. I feel the same way about those who are trying to control marijuana in the USA. They are the new drug lords and I find them disgusting. If any of that is what you are into, grow your own. I long for the appearance of Johnny Appleseed types, willing and able to spread bud seed wherever it will take root. That is the type of pushback we need.

mickey

[mickey]

More about growing your own,

A few years ago, in NYC, we had a situation where people were getting seriously stretched out, I mean really stretched out and motionless, in the streets. This happened in Williamsburg Brooklyn, near the Claremont section of The Bronx, and in East Harlem. The people were all in the vicinity of drug treatment centers. One person made mention of how participants in these programs use K2 (a marijuana substitute) so they would not test dirty with their drug testing. No follow up was done to find out if there was a connection or a change in the formula. The people were picked up by the ambulance and driven away, not to be seen again.

The only other time I have seen anything similar was when crystal meth was first introduced. It was initially called "ice".

mickey

[GeneChing]

Mike Tyson says he uses psychedelics in training. Now meet some of the others.
Josh Peter
USA TODAY

When you’ve lived with tigers, tattooed your face and bitten off a piece of another man’s ear in the boxing ring, it’s hard to shock anyone.

But Mike Tyson generated buzz during a recent appearance on Logan Paul's podcast when he said he consumes mushrooms of the psychedelic variety while he's training for his fight against Jake Paul on Nov. 15.

"It takes me to heaven, baby,'' Tyson said.

The former heavyweight champion is not alone when it comes to the use of "magic'' mushrooms during high-performance training.

According to athletes and those familiar with the practice, a number of professional hockey players, professional golfers and MMA fighters are using psilocybin, which is the naturally occurring psychedelic drug also known as “magic mushrooms," during training and in some cases during competition.

Heightened awareness and faster recovery are among reported benefits from “microdosing’’– taking a fraction of the regular dose of the drug and experiencing no psychoactive effect. (That does not appear to be the case with Tyson.)

“It makes you feel much more present,’’ said Ara Suppiah, a physician who has worked with Ryder Cup teams and estimated 4% to 5% of pro golfers are microdosing mushrooms. He declined to name the golfers but said they were not any he works with.

Pro golfer D.J. Trahan, who won PGA Tour events in 2006 and 2008, said the use of psychedelics starting in 2019 profoundly improved his well-being. He said his golf career has struggled despite microdosing off and on since 2021. But Trahan told USA TODAY Sports, "I know quite a few guys that are microdosing, and they have had tremendous success doing it, really. And I'm not at liberty to say anybody's names, nor would I, because it's not my place."

Riley Cote, a retired NHL player, said he knows at least a dozen active NHL players microdosing mushrooms. He declined to name the players. Known as an enforcer, Cote has said he suffered concussions during on-ice fights and started using psilocybin after his NHL career ended in 2010 for physical and mental health issues.

“This is not even about just the hockey performance or sports performance, it's just life performance,’’ said Cote, who played in 156 games for the Philadelphia Flyers between 2006 and 2010. “And I think it just extends to all of these different crafts because naturally high-end performers are always going to try and find an edge.’’


Mike Tyson arrives on the red carpet before the 2023 ESPYS.
Rashad Evans, a former UFC light heavyweight champion who fought last in 2022, said he knows at least 30 UFC fighters who microdose regularly. He said he used mushrooms while training for his fight in 2022 and the drugs reduced soreness after sparring.

“The next day I feel totally rebooted and ready to do it again,’’ said Evans, who at 42 beat 35-year-old Gabriel Checco by unanimous decision.

When did athletes start using mushrooms?

It was eight years ago when Suppiah first heard of microdosing mushrooms in the world of golf, the physician said.

That was the same time PGA Tour player Morgan Hoffman disappeared into the Costa Rican jungle after being diagnosed with muscular dystrophy and emerged a vocal advocate of psychedelics. He rejoined the Tour in 2022.

Also, Suppiah said, podcasts such as "The Joe Rogan Experience" helped spread the word.

“They had guests on who started talking about microdosing,’’ Suppiah said. “Joe Rogan talked about microdosing. And those things are, podcasts, generally are very popular among golfers.’’

With a connection to Riley, Bramlage said he began working with hockey players six years ago.

Ian McCall, a retired MMA fighter, said he began working with other fighters five years ago. “But I didn’t see it take off until two years ago,’’ he said. One of his clients is Mark Irwin, a 36-year-old bareknuckle brawler from Southern California who said he took 7.5 grams of mushrooms the night he won the BYB Extreme lightweight title in 2023 – and was on mushrooms again when he lost the title later in the year.

Ultrarunner Michael Versteeg has talked about using mushrooms in training and in competition.

But it was Tyson whose open use of the drug raised its profile in the world of athletics. He credited psychedelics for turning around his life and said he used mushrooms while training for his exhibition fight with Roy Jones Jr. in 2020.

Adam Bramlage, who specializes in microdosing and said he works with a dozen NHL players and two snowboarders, said the average dosage for microdosing is 100 to 150 milligrams. He said it's ingested an hour or two before training or performance and lasts four to six hours.

A two-month supply costs $100 to $200, according to Bramlage.

"Whether it's Mike Tyson or it's my NHL athletes, they get into a flow state where they're no longer thinking about what they have to do later or what they did yesterday or the stressors of their life,'' he said. "They're just in the present moment.''

continued next post

[GeneChing]

What are the risks?

Psychedelic mushrooms are not approved for use by the Food and Drug Administration (FDA) and, classified as a Schedule I substance under the Controlled Substances Act, they're illegal under federal law.

In Oregon and Colorado, however, residents voted to make the supervised use of psilocybin legal. There's a push to legalize the drug elsewhere, with one of several studies showing benefits such as treating addiction, depression and end-of-life mood disorders.

There’s no risk of a positive drug test for those athletes because it is not on the World Anti-Doping Agency list of prohibited substances. But Suppiah said he thinks that could change..

“The only question I have is are they going to look at it and say, is this an unfair advantage?’’ he said. “Is this performance enhancing and is it Adderall where you need a (Therapeutic Use Exemption) to say, 'I have an attention deficit disorder, therefore I'm allowed to take this medication?' ’’

WADA’s Prohibited List, according to communications manager Andrew Maggio, may include any substance or method that satisfies two of the following three criteria:

It has the potential to enhance or enhances sport performance.
It represents an actual or potential health risk to the athlete.
It violates the spirit of sport (this term is defined in the World Anti-Doping Code).

Based on current knowledge, Maggio said, psychedelics, including psilocybin, do not fulfill two of the three criteria to be considered for inclusion on the list.

The use of mushrooms does have potential health risks, according to the National Institute on Drug Abuse, which lists the following health risks: increased heart rate and blood pressure; nausea and vomiting; extreme fear, panic and paranoia; and flashbacks.

How mushrooms have impacted Tyson

There is no evidence mushrooms are a performance-enhancing drug, said Matt Johnson, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics in Maryland. Previously at John Hopkins, Johnson's clinical trials have explored the effects of psychedelics on mystical experience, personality change, cancer distress treatment and depression treatment, according to his bio at Sheppard Pratt's Institute.

But Johnson said he is open to the possibility based on Tyson reporting benefits. “I don't dismiss it out of hand,’’ Johnson said. “If Mike Tyson says something enhances his performance, I'd weigh that. Again, not as proof, but I'd weigh that with serious consideration.

“I think the guy knows something about what affects his performance most likely. It doesn't mean that he's not susceptible to a placebo effect, but again, pretty open and it's plausible. So yeah, I am curious about the whole situation for sure.’’


Mike Tyson and Jake Paul pose onstage during the press conference for their upcoming fight.
A publicist for Tyson, 58, did not respond to a request for comment submitted by USA TODAY Sports by email and text message.

Tyson’s recent appearance on the Logan Paul show was not the first time he’s discussed using mushrooms. Three years earlier, also on Paul’s podcast, he shoved a fistful of dry mushrooms in his mouth. Johnson, the researcher, noted that most people would not be able to train on high doses of mushrooms.

Tyson has credited the drug with helping him lose 100 pounds, give up cocaine and alcohol and improve his relationships with his wife and children. And for his return to boxing.

Last month, Tyson launched an at-home mushroom grow kit as part of a business collaboration featuring TYSON 2.0, the boxer's cannabis brand.

But, in an interview that took place after Tyson experienced what his representatives described as an ulcer flareup that forced the fight to be postponed, he indicated he would have to speak to his doctor before using mushrooms. Based on his comments on Paul’s podcast, he appeared to have gotten approval.

"And he's not saying, 'I'm punching harder,' " said James Fadiman, a researcher of psychedelics and author of The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys. "But he is saying, 'I can get in touch with that particular part of myself more easily.' "

Actually, when Logan Paul asked Tyson why he uses mushrooms during his workouts, this is exactly what he said:

“Because I feel beautiful.''

Follow Josh Peter on social media @joshlpeter11

Tyson-v-Paul
the-magic-of-mushrooms

[GeneChing]

Austrian man amputated his ***** with an axe after eating psilocybin psychedelic mushrooms
A magic mushroom-induce psychosis led to the man amputating his own *****.
By Amber Louise Bryce

Published on 30/09/2024 - 17:31 GMT+2•Updated 17:41

Psilocybin has become increasingly popular in medical research for its potential therapeutic benefits, but an extreme case has highlighted the drug’s potential dangers when used in uncontrolled settings.
An Austrian man amputated his ***** with a blunt axe after consuming a large dose of psilocybin mushrooms, storing its fragments in a jar with soil and dirty snow.
Doctors were mostly able to reattach the ***** fragments after disinfecting and debriding them, according to a report of the extreme case in the Mega Journal of Surgery.
Psilocybin is a naturally occurring psychedelic compound found in magic mushrooms.
Once ingested, the body converts it to psilocin, a chemical with psychoactive properties that can cause hallucinations, altering a person’s perceptions of the world and their emotional states.
While often used recreationally, psilocybin has become a popular subject in medical research as a potential treatment for mental health conditions, such as anxiety, depression and post-traumatic stress disorder (PTSD), with 20 studies currently complete or under way to test it in the European Union.
A recent study published in Translational Psychiatry found that the drug showed promise in treating depression by increasing positive mood and alleviating negative thought patterns, while another study by the Washington University School of Medicine in St Louis documented how psilocybin could impact peoples’ perceptions of space and time, making them more open and flexible.
However, outside of the controlled environments of clinical laboratories, psilocybin can be potentially dangerous - especially in those with pre-existing mental health disorders that cause psychosis.
The report, conducted by the department of Academic Teaching at the Hospital Feldkirch in Austria, details how the caucasian man, 37, who had a history of depression and "occasional excessive alcohol abuse," consumed four or five dried magic mushrooms while alone at his holiday home.
Shortly after the mushroom’s effects took hold, the man cut his ***** into four pieces with an axe, then panickedly ligated the stump with a cloth and stored the severed fragments in a jar.
Confused and bleeding out, he went searching for help until a passerby found him and took him to a nearby village where an ambulance arrived - roughly five hours after the incident had occurred.
The man had no clear recollection of the event.
Having lost a significant amount of blood and in a critical condition, the patient was rushed into surgery, according to the report, where doctors managed to save the tip of the ***** and 2 cm of the penile shaft, reattaching them macroscopically.
The surgery was largely successful, with the patient healing well and reported to have “a good urinary stream and erections” four months later - although a total length of 5 cm had to be removed, and a slight complication in the form of coronal hypospadias developed, where the urethra opens further down the ***** shaft than normal.
The man was also placed under intensive psychiatric care and given medications after continuing to show psychotic symptoms and religious delusions.
Rare incident

In controlled settings, psilocybin has been shown to be an effective therapeutic drug for certain mental health conditions. Canva
This is the first reported case of psilocybin-induced self-amputation or Klingsor syndrome, a rare condition that involves self-inflicted penile amputation, as reported by the Open Journal of Urology.
While this is an extreme example of the dangers of psilocybin in just one individual, the case report does highlight the potential risks the drug has when used by individuals with more severe underlying mental health conditions that involve the presence of psychosis.
"Psilocybin therapy has been tested successfully in patients with major depressive disorder. However, aside from its therapeutic effects, in patients consuming high doses of psilocybin, experiences of fear and paranoia have been reported in up to 31 per cent and 17 per cent, respectively," the study states.
"Due to lack of protocols on how to handle this rare entity, reporting these cases is important to gain experience,” it concludes.
For the most part, however, research on psychedelic drugs - when used in controlled environments - continues to show promising potential benefits on mental health conditions.
A study published in the Journal of Psychopharmacology, which looked at magic mushroom-related adverse reactions resulting in emergency medical treatment, found such incidents to be rare.
"Magic mushrooms are relatively innocuous substances and rarely cause harm to the individual consuming them nor to other people. Most adverse reactions are short-lived, and their risk can be minimised with certain safety precautions".

As many of you know, I specialize in deescalating intense psychedelic reaction cases at concerts and festivals. This case is beyond the pale.

[BeaterWhacker]

Precisely why it is wise to harvest them and ingest them yourselves.